(Total Views: 401)
Posted On: 05/17/2023 1:45:24 PM
Post# of 8451
Fierce Biotech M&A Tracker 2023
May 17, 2023
"Acquisitions are back, biotech. After a stagnant year with pharma sitting on a heap of cash, the fruits of in-person business development meetings are beginning to ripen."
XinThera
Date: May 9
Buyer: Gilead Sciences
Price: Undisclosed
Iveric Bio
Date: May 1
Buyer: Astellas Pharma
Price: $5.9 billion
Bellus Health
Date: April 18
Buyer: GSK
Price: $2 billion
Satsuma Pharmaceutical
Date: April 17
Buyer: Shin Nippon Biomedical Laboratories
Price: $0.91 per share, estimated $30 million
Prometheus Biosciences
Date: April 17
Buyer: Merck & Co.
Price: $10.8 billion
StrideBio
Date: April 5
Buyer: Ginkgo Bioworks
Price: Undisclosed
Diffusion Pharmaceuticals
Date: March 30
Buyer: EIP Pharma
Price: N/A
Jounce Therapeutics
Date: March 27
Buyer: Concentra Biosciences
Price: $1.85 per share, estimated $97.4 million
More M&A here, https://www.fiercebiotech.com/biotech/fierce-...acker-2023
May 17, 2023
"Acquisitions are back, biotech. After a stagnant year with pharma sitting on a heap of cash, the fruits of in-person business development meetings are beginning to ripen."
XinThera
Date: May 9
Buyer: Gilead Sciences
Price: Undisclosed
Iveric Bio
Date: May 1
Buyer: Astellas Pharma
Price: $5.9 billion
Bellus Health
Date: April 18
Buyer: GSK
Price: $2 billion
Satsuma Pharmaceutical
Date: April 17
Buyer: Shin Nippon Biomedical Laboratories
Price: $0.91 per share, estimated $30 million
Prometheus Biosciences
Date: April 17
Buyer: Merck & Co.
Price: $10.8 billion
StrideBio
Date: April 5
Buyer: Ginkgo Bioworks
Price: Undisclosed
Diffusion Pharmaceuticals
Date: March 30
Buyer: EIP Pharma
Price: N/A
Jounce Therapeutics
Date: March 27
Buyer: Concentra Biosciences
Price: $1.85 per share, estimated $97.4 million
More M&A here, https://www.fiercebiotech.com/biotech/fierce-...acker-2023
(2)
(0)
